Literature DB >> 6833494

Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance.

J S Hoffman, E P Benditt.   

Abstract

The plasma clearance kinetics of the amyloid-related high density lipoprotein (HDL) apoprotein serum amyloid protein (apoSAA) was examined in BALB/c mice by two different methods, using labeled 125I-apoSAA-rich HDL and unlabeled plasma apoSAA (clearance monitored by radioimmunoassay). The plasma half-life of apoSAA, estimated by both methods, was on the order of 75-80 min, as compared with a value of approximately 11 h for mouse apoA-I. In trace-labeling studies, the rapid plasma clearance of both major 125I-labeled apoSAA isotypes was observed; this metabolic behavior was unique to these polypeptides among HDL apoproteins. The property of rapid plasma clearance was lost upon purification and reconstitution of 125I-apoSAA with HDL, indicating that this property is labile to denaturing conditions. Studies aimed at determining the metabolic fate of 125I-apoSAA gave no evidence for either the selective excretion of 125I-apoSAA or clearance to unique tissue sites as compared with other 125I-HDL apoproteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833494      PMCID: PMC436950          DOI: 10.1172/jci110847

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Amphipathic helixes and plasma lipoproteins: a computer study.

Authors:  J P Segrest; R J Feldmann
Journal:  Biopolymers       Date:  1977-09       Impact factor: 2.505

2.  A simplified method for the quantitative assay of small amounts of protein in biologic material.

Authors:  G R Schacterle; R L Pollack
Journal:  Anal Biochem       Date:  1973-02       Impact factor: 3.365

3.  Chemical similarity among amyloid substances associated with long standing inflammation.

Authors:  E P Benditt; N Eriksen
Journal:  Lab Invest       Date:  1972-06       Impact factor: 5.662

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Isolation and characterization of amyloid-related serum protein SAA as a low molecular weight protein.

Authors:  R F Anders; J B Natvig; T E Michaelsen; G Husby
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

6.  Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions.

Authors:  J S Hoffman; E P Benditt
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

7.  Variation with age and disease of an amyloid A protein-related serum component.

Authors:  C J Rosenthal; E C Franklin
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

8.  Metabolism of chromatographically separated rat serum lipoproteins specifically labeled with 125I-apolipoprotein E.

Authors:  F van't Hooft; R J Havel
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

9.  Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats.

Authors:  M A Freudenberg; T C Bøg-Hansen; U Back; C Galanos
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  Amyloid-related serum protein SAA from three animal species: comparison with human SAA.

Authors:  R F Anders; J B Natvig; K Sletten; G Husby; K Nordstoga
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

View more
  18 in total

1.  SAA: a link between cholesterol efflux capacity and inflammation?

Authors:  Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Lipid Res       Date:  2015-06-15       Impact factor: 5.922

2.  Human serum amyloid A protein. Behaviour in aqueous and urea-containing solutions and antibody production.

Authors:  A F Strachan; E G Shephard; D U Bellstedt; G A Coetzee; D R van der Westhuyzen; F C de Beer
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

3.  Serum amyloid A in the mouse. Sites of uptake and mRNA expression.

Authors:  R L Meek; N Eriksen; E P Benditt
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

Review 4.  Reactive (secondary) amyloidosis and its pathogenesis.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

5.  Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Richard J Charnigo; Ailing Ji; Nancy R Webb; Frederick C de Beer; Deneys R van der Westhuyzen
Journal:  J Lipid Res       Date:  2016-03-27       Impact factor: 5.922

6.  Identification of three isoform patterns of human serum amyloid A protein.

Authors:  A F Strachan; F C de Beer; D R van der Westhuyzen; G A Coetzee
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

7.  Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases.

Authors:  C P Maury
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

8.  Adenoviral expression of murine serum amyloid A proteins to study amyloid fibrillogenesis.

Authors:  M S Kindy; A R King; J Yu; C Gerardot; J Whitley; F C de Beer
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

9.  Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters.

Authors:  I Hardardóttir; A H Moser; J Fuller; C Fielding; K Feingold; C Grünfeld
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function.

Authors:  R L Meek; S Urieli-Shoval; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.